Back to Erste Asset Management GmbH Erste Asset Management GmbH

KYMR

Showing 9 of 19 quarters

Position history for Erste Asset Management GmbHErste Asset Management GmbH's holdings in Kymera Therapeutics, Inc.

Yes. Erste Asset Management holds 27,000 shares of KYMR (Kymera Therapeutics), worth $3M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Erste Asset Management has held KYMR since Q1 2022, across 19 quarterly 13F filings.

Current Value

$3M

Current Shares

27,000

Total Value Change

+$1.7M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
27,000
0.0%
$3M0.0%$111.79
0
2026-Q2
Unchanged
27,000
0.0%
$3M0.0%$114.67
0
2026-Q1
Unchanged
27,000
0.0%
$2.1M0.0%$83.29
0
2025-Q4
Unchanged
27,000
0.0%
$2.2M0.0%$77.81
0
2025-Q3
Unchanged
27,000
0.0%
$1.6M0.0%$56.60
0
2025-Q2
Unchanged
27,000
0.0%
$1.2M0.0%$43.64
0
2025-Q1
Unchanged
27,000
0.0%
$799,7400.0%$27.37
0
2024-Q4
Unchanged
27,000
0.0%
$1.1M0.0%$40.23
0
2024-Q3
Unchanged
27,000
0.0%
$1.3M0.0%$47.33
0

Other major holders of KYMR: FMR LLC, Baker Bros. Advisors LP, Avoro Capital Advisors LLC

Optional analytics helps us improve. How it’s used